Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

1071-1080 of 1570 results

Catalogue Number:

orb1517463

Category:

MS4A1 Antibody

Target:	MS4A1
Target Alias Names:	MS4A1, CD20, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1, CD antigen CD20
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Human IgG1
Host Species:	Human
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1517464

Category:

MS4A1 Antibody

Target:	MS4A1
Target Alias Names:	APY antibody, ATOPY antibody, B lymphocyte antigen CD20 antibody, B Lymphocyte Cell Surface Antigen B1 antibody, B-lymphocyte antigen CD20 antibody, B-lymphocyte cell-surface antigen B1 antibody, B-lymphocyte surface antigen B1 antibody, B1 antibody, Bp 35 antibody, Bp35 antibody, CD 20 antibody, CD20 antibody, CD20 antigen antibody, CD20 receptor antibody, CD20_HUMAN antibody, CVID 5 antibody, CVID5 antibody, Fc epsilon receptor I beta chain antibody, Fc Fragment of IgE high affinity I receptor for beta polypeptide antibody, FCER1B antibody, High affinity immunoglobulin epsilon receptor subunit beta antibody, IgE Fc receptor subunit beta antibody, IGEL antibody, IGER antibody, IGHER antibody, LEU 16 antibody, Leu-16 antibody, LEU16 antibody, leukocyte surface antigen Leu 16 antibody, Leukocyte surface antigen Leu-16 antibody, Ly44 antibody, Membrane spanning 4 domains A1 antibody, Membrane spanning 4 domains subfamily A member 2 antibody, membrane-spanning 4-domains A1 antibody, Membrane-spanning 4-domains subfamily A member 1 antibody, MGC3969 antibody, MS4A1 antibody, MS4A2 antibody, S7 antibody
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Human IgG1
Host Species:	Human
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1743599

Category:

MS4A1 Antibody

Target:	MS4A1
Target Alias Names:	APY antibody, ATOPY antibody, B lymphocyte antigen CD20 antibody, B Lymphocyte Cell Surface Antigen B1 antibody, B-lymphocyte antigen CD20 antibody, B-lymphocyte cell-surface antigen B1 antibody, B-lymphocyte surface antigen B1 antibody, B1 antibody, Bp 35 antibody, Bp35 antibody, CD 20 antibody, CD20 antibody, CD20 antigen antibody, CD20 receptor antibody, CD20_HUMAN antibody, CVID 5 antibody, CVID5 antibody, Fc epsilon receptor I beta chain antibody, Fc Fragment of IgE high affinity I receptor for beta polypeptide antibody, FCER1B antibody, High affinity immunoglobulin epsilon receptor subunit beta antibody, IgE Fc receptor subunit beta antibody, IGEL antibody, IGER antibody, IGHER antibody, LEU 16 antibody, Leu-16 antibody, LEU16 antibody, leukocyte surface antigen Leu 16 antibody, Leukocyte surface antigen Leu-16 antibody, Ly44 antibody, Membrane spanning 4 domains A1 antibody, Membrane spanning 4 domains subfamily A member 2 antibody, membrane-spanning 4-domains A1 antibody, Membrane-spanning 4-domains subfamily A member 1 antibody, MGC3969 antibody, MS4A1 antibody, MS4A2 antibody, S7 antibody
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Mouse IgG2a
Host Species:	Mouse
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb757394

Category:

MSLN Antibody

Target:	Mesothelin
Target Alias Names:	MSLN, Mesothelin, MPF
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb757395

Category:

MSLN Antibody

Target:	Mesothelin
Target Alias Names:	MSLN, Mesothelin, MPF
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb757396

Category:

MSLN Antibody

Target:	Mesothelin
Target Alias Names:	MSLN, Mesothelin, MPF
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb689326

Category:

MSLN Antibody

Target:	MSLN
Target Alias Names:	MSLN, Mesothelin, MPF
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Other
Formulation:	Powder
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1291209

Category:

MST1R Antibody

Target:	MST1R
Target Alias Names:	CD136, CDw136, NPCA3, PTK8, RON
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Formulation:	Powder
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb572556

Category:

MTOR (Phospho-S2448) antibody

Target:	MTOR
Target Alias Names:	Serine/threonine-protein kinase mTOR, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, Mammalian target of rapamycin, mTOR, Mechanistic target of rapamycin, Rapamycin and FKBP12 target 1, Rapamycin target protein 1, MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Species Reactivity:	Human
Applications:	ELISA, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb572536

Category:

MTOR (Phospho-S2481) antibody

Target:	MTOR
Target Alias Names:	Serine/threonine-protein kinase mTOR, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, Mammalian target of rapamycin, mTOR, Mechanistic target of rapamycin, Rapamycin and FKBP12 target 1, Rapamycin target protein 1, MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Species Reactivity:	Human
Applications:	ELISA, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Viewing 1071-1080 of 1570 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.